Stay updated on Idasanutlin Combo in AML: Clinical Trial
Sign up to get notified when there's something new on the Idasanutlin Combo in AML: Clinical Trial page.

Latest updates to the Idasanutlin Combo in AML: Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now displays a 403 Forbidden error for the study record, replacing detailed study content with a minimal error header and a Home link, and a site revision tag appears as part of the new page state.SummaryDifference19%

- Check48 days agoChange DetectedThe page now includes a 2014 NIH grant/contract attribution and shows the revision updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page revision has been updated from v3.6.4 to v3.6.5. This indicates a new version of the study page without changes to the content.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision: v3.6.4 replaces v3.6.3 on the page, signaling a patch release. The study details page content appears unchanged to users.SummaryDifference0.0%

- Check105 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. This reflects a minor metadata update to the page without altering substantive content.SummaryDifference0.0%

Stay in the know with updates to Idasanutlin Combo in AML: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Idasanutlin Combo in AML: Clinical Trial page.